National Research Corporation Sees Spike in Short Interest

Short interest in the healthcare analytics firm grew by over 33% in February

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

National Research Corporation (NASDAQ:NRC), a healthcare analytics and performance improvement company, saw a significant increase in short interest during the month of February. As of February 13th, short interest totaled 471,736 shares, a 33.7% jump from the 352,823 shares reported on January 29th. This represents 2.1% of the company's outstanding shares, with the short-interest ratio currently at 2.7 days based on the stock's average daily trading volume.

Why it matters

The rise in short interest suggests that some investors are betting against National Research Corporation's stock performance in the near term. This could be due to concerns about the company's financial outlook or broader market conditions. However, the relatively low short-interest ratio indicates that the stock is not heavily shorted, so the impact on the share price may be limited.

The details

National Research Corporation is a healthcare analytics and performance improvement company that specializes in patient and employee experience measurement. The company's cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. The company has expanded beyond its regional roots in Lincoln, Nebraska to serve over 1,600 hospitals and 12,000 care sites across the United States and Canada.

As of February 13th, 2026, short interest in National Research Corporation totaled 471,736 shares.
On January 29th, 2026, short interest in the company was 352,823 shares.

The players